Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Abbott Laboratories issues FY 2014 EPS guidance in line with analysts' estimates

Wednesday, 22 Jan 2014 07:44am EST 

Abbott Laboratories:Expects FY 2014 EPS in the range of $2.16-$2.26, representing double-digit growth at the mid-point of the guidance range.FY 2014 EPS of $2.21 - Thomson Reuters I/B/E/S.